Accelerated rTMS for Post-Stroke Apathy
NCT: NCT05878457 · COMPLETED
Brief Summary
This pilot study will investigate the safety, feasibility, tolerability, and preliminary efficacy of accelerated high-dose repetitive transcranial magnetic stimulation (rTMS) targeting the medial prefrontal cortex (mPFC) to address apathy symptoms in individuals with chronic stroke.
Frequently Asked Questions
What is Accelerated rTMS for Post-Stroke Apathy?
Accelerated rTMS for Post-Stroke Apathy is a clinical trial registered under NCT05878457. Current status: COMPLETED.
What is the status of NCT05878457?
The current status of NCT05878457 (Accelerated rTMS for Post-Stroke Apathy) is: COMPLETED.
When did Accelerated rTMS for Post-Stroke Apathy start?
Accelerated rTMS for Post-Stroke Apathy started on 2023-12-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.